COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 95 filers reported holding COHERUS BIOSCIENCES INC in Q3 2017. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,707 | -27.4% | 456,585 | -17.1% | 0.00% | -33.3% |
| Q2 2023 | $2,350 | -8.9% | 550,523 | +45.9% | 0.00% | 0.0% |
| Q1 2023 | $2,580 | +2.5% | 377,333 | +18.8% | 0.00% | 0.0% |
| Q4 2022 | $2,516 | -99.8% | 317,722 | +97.4% | 0.00% | +50.0% |
| Q3 2022 | $1,546,000 | +2520.3% | 160,976 | +1857.9% | 0.00% | – |
| Q2 2022 | $59,000 | -80.0% | 8,222 | -64.1% | 0.00% | – |
| Q1 2022 | $295,000 | -60.1% | 22,888 | -50.6% | 0.00% | -100.0% |
| Q4 2021 | $740,000 | +487.3% | 46,374 | +491.3% | 0.00% | – |
| Q3 2021 | $126,000 | -59.0% | 7,843 | -64.7% | 0.00% | – |
| Q2 2021 | $307,000 | -75.3% | 22,217 | -73.9% | 0.00% | -100.0% |
| Q1 2021 | $1,242,000 | +19.3% | 85,076 | +42.0% | 0.00% | +100.0% |
| Q4 2020 | $1,041,000 | +47.9% | 59,897 | +22.0% | 0.00% | 0.0% |
| Q2 2017 | $704,000 | – | 49,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
| CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
| Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
| Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
| Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
| Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
| Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
| Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
| Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |